Bin Xu - Publications

Affiliations: 
Chemistry shanghai university, Shanghai, Shanghai Shi, China 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhang X, Ma S, Zhang R, Li S, Zhu D, Han D, Li X, Li C, Yan W, Sun D, Xu B, Wang Y, Cao F. Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway. Acta Biochimica Et Biophysica Sinica. PMID 26837420 DOI: 10.1093/abbs/gmv137  0.332
2004 Jacobson KA, Costanzi S, Ohno M, Joshi BV, Besada P, Xu B, Tchilibon S. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Current Topics in Medicinal Chemistry. 4: 805-19. PMID 15078212 DOI: 10.2174/1568026043450961  0.631
2003 Kim HS, Ohno M, Xu B, Kim HO, Choi Y, Ji XD, Maddileti S, Marquez VE, Harden TK, Jacobson KA. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. Journal of Medicinal Chemistry. 46: 4974-87. PMID 14584948 DOI: 10.1021/Jm030127+  0.564
2002 Xu B, Stephens A, Kirschenheuter G, Greslin AF, Cheng X, Sennelo J, Cattaneo M, Zighetti ML, Chen A, Kim SA, Kim HS, Bischofberger N, Cook G, Jacobson KA. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. Journal of Medicinal Chemistry. 45: 5694-709. PMID 12477353 DOI: 10.1021/Jm020173U  0.559
Show low-probability matches.